Santa Clarita Congressman Co-sponsors Legislation To Lower Cost Of Prescription Drugs hometownstation.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from hometownstation.com Daily Mail and Mail on Sunday newspapers.
UPDATED 7:25 PM ET Aug. 04, 2021 PUBLISHED 6:28 PM ET Aug. 04, 2021 PUBLISHED 6:28 PM EDT Aug. 04, 2021
SHARE
WASHINGTON For the millions of Americans with brain diseases and disorders, many of them incurable and degenerative, life often is filled with challenges and uncertainty. 34-year-old Kala Booth of Cecilia, Kentucky is the fourth generation in her family to have Huntington’s Disease, a brain disorder caused by a defective gene that impacts movement, mood and thinking skills.
She saw firsthand how it ravaged her grandfather. In the late 90 s/early 2000 s, when I should have been creating memories with my papaw, I was emotionally disconnecting from him. Huntington’s Disease had turned this previously gentle man into someone who beat my mamaw black and blue, someone we needed to keep a phone nearby in case we needed to call 911, said Booth at a U.S. House Health, Energy and Commerce
·
·
Establish an annual out-of-pocket cap of $3,100 for Medicare Part D enrollees and allow certain patients to pay in monthly installments;
·
Decrease beneficiary cost sharing from 25 percent to 15 percent of costs before the out-of-pocket cap is reached;
·
Allow prescription drug plan sponsors to offer, at minimum, up to four Part D plans per region, spurring competition and innovation;
·
Make permanent the Center for Medicare and Medicaid Innovation model that enables Part D enrollees taking insulin to limit out-of-pocket costs to $35;
·
·
Provide the HHS Secretary with the authority to require drug manufacturers to provide pricing information on all direct-to-consumer advertising;
·
Codify a Trump Administration regulatory action that classifies insulin and other treatments for chronic conditions as preventative care so that high deductible health p
Standing up for bipartisanship against government takeover of prescription drug prices Follow Us
Question of the Day
ANALYSIS/OPINION:
During the recent address to the Joint Session of Congress, President Joe Biden said, “Now, look, if you don’t like my plan, let’s at least pass what we all agree on.” I agree with his sentiment broadly, and my goal as the Republican Leader of the Energy and Commerce Committee’s Health Subcommittee is to find areas that we can agree on in order to deliver real results for our constituents. That’s why I support H.R. 19, the Lower Costs, More Cures Act to lower prescription drug costs.
An agreement on infrastructure emerges. Wyden releases drug pricing principles. Upton and DeGette introduce long-awaited ‘Cures 2.0’ draft legislation. Us Set to miss July 4 vaccination goal.